## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)βpositive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi
β¦ LIBER β¦
Research review: treatment of breast cancer with tamoxifen in older women with estrogen receptor-positive breast cancer: motivational issues
β Scribed by Barbara Resnick
- Book ID
- 113637628
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 86 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1528-3984
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Risk of early recurrence among postmenop
β
Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik
π
Article
π
2008
π
John Wiley and Sons
π
English
β 162 KB
π 1 views
Predicting prognosis using molecular pro
β
Sherene Loi; Benjamin Haibe-Kains; Christine Desmedt; Pratyaksha Wirapati; FranΓ§
π
Article
π
2008
π
BioMed Central
π
English
β 464 KB
Adjuvant tamoxifen for pre- and postmeno
β
S. Gundersen; E. Hannisdal; J. A. SΓΈreide; A. Skarstein; J. E. Varhaug
π
Article
π
1995
π
Springer US
π
English
β 368 KB
329 Tamoxifen in premenopausal patients
β
A.H.G. Paterson
π
Article
π
1983
π
Elsevier Science
π
English
β 131 KB
An estrogen receptor genetic polymorphis
β
Steven P. Lehrer; Rita K. Schmutzler; Jill M. Rabin; Beth S. Schachter
π
Article
π
1993
π
Springer US
π
English
β 434 KB
Association of estrogen receptor Ξ± polym
β
Francesmary Modugno; Joseph M. Zmuda; Douglas Potter; Chao Cai; Elad Ziv; Steven
π
Article
π
2005
π
John Wiley and Sons
π
French
β 114 KB
π 1 views
## Abstract Estrogens exert their effect on the breast through the estrogen receptor. We prospectively investigated breast cancer risk associated with 2 polymorphic sites in the estrogen receptor alpha gene (__ESR1__). A total of 4,248 Caucasian women from the Study of Osteoporotic Fractures were g